by GlobeNewsWire | Jul 13, 2016 | Globe Newswire
ST. LOUIS, July 13, 2016 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the University of Chicago Medicine will implement the Company’s Niobe® ES...
by GlobeNewsWire | Jul 8, 2016 | Globe Newswire
ST. LOUIS, July 08, 2016 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that Texas Children’s Hospital in Houston has installed the Company’s Niobe® ES...
by GlobeNewsWire | Jun 1, 2016 | Globe Newswire
ST. LOUIS, June 01, 2016 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of a retrospective study conducted at Paracelsus Medical University in...
by GlobeNewsWire | Mar 18, 2016 | Globe Newswire
ST. LOUIS, March 18, 2016 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the first patients treated with the Niobe® ES remote magnetic navigation system at...
by GlobeNewsWire | Feb 22, 2016 | Globe Newswire
New capital orders of $5.1 million in the fourth quarter, including two Niobe® ES system orders in JapanFourth quarter free cash flow of $1.6 million, driving a 71% reduction in full year cash burn compared to 2014Ventricular Tachycardia procedures in the fourth...